New insights into HIV-1-primary skin disorders

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Cedeno Laurent, Filiberto ^a,b   Gámez Flores, Minerva ^c   Mendez, Nora ^c   Ancer Rodríguez, Jess ^c   Bryant, Joseph L ^a   Gaspari, Anthony A ^d   Trujillo, Jose R ^e  

^a UNIVERSITY OF MARYLAND   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

XENOBIOTIC AGENT; ZIDOVUDINE;

ATOPIC DERMATITIS; ATYPICAL MYCOBACTERIOSIS; AUTOIMMUNITY; BACILLARY ANGIOMATOSIS; BASAL CELL CARCINOMA; CANDIDIASIS; CRYPTOCOCCOSIS; DERMATOPHYTE; DISEASE MODEL; DISEASE SEVERITY; ECTHYMA; EOSINOPHIL FOLLICULITIS; ERYTHRODERMA; FAMILY HISTORY; FOLLICULITIS; HERPES SIMPLEX; HISTOPATHOLOGY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMPETIGO BULLOSA; INNATE IMMUNITY; KAPOSI SARCOMA; MOLLUSCUM CONTAGIOSUM; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PSORIASIS; REITER SYNDROME; REVIEW; SEBORRHEIC DERMATITIS; SKIN DISEASE; SKIN PRURITUS; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS INFECTION; T CELL LYMPHOMA; TRANSGENIC ANIMAL; TREATMENT RESPONSE; VARICELLA ZOSTER VIRUS; VERRUCA VULGARIS; VIRUS GENE; XEROSIS; AIDS RELATED COMPLEX; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; HIV-1; HUMANS; SKIN; SKIN DISEASES;

EID: 78751645177     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-5     Document Type: Review

References (117)

1. Dermatologic manifestations of human immunodeficiency virus infection. MJ Zalla WP Su AF Fransway, Mayo Clin Proc 1992 67 1089 1108 1434871
2. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. MA Munoz-Perez A Rodriguez-Pichardo F Camacho MA C (Pubitemid 28338061)
3. Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. WB Bernstein RF Little WH Wilson R Yarchoan, Int J Hematol 2006 84 3 11 10.1532/IJH97.06088 16867895 (Pubitemid 44756769)
4. Dermatologic manifestations of HIV infection. TA Maurer, Top HIV Med 2005 13 149 154 16377853
5. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. S Uthayakumar R Nandwani T Drinkwater AT Nayagam CR Darley, Br J Dermatol 1997 137 595 598 10.1111/j.1365-2133.1997. tb03793.x 9390338 (Pubitemid 27469513)
6. HIV-related skin diseases. E Tschachler PR Bergstresser G Stingl, Lancet 1996 348 659 663 10.1016/S0140-6736(96)01032-X 8782758 (Pubitemid 26293813)
7. Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis. P Amerio R Verdolini G Proietto C Feliciani P Toto G Shivji F Loconsole N Cassano P Amerio G Vena DN Sauder, Acta Derm Venereol 2001 81 92 95 10.1080/00015550152384191 11501668 (Pubitemid 32662146)
8. Role of endogenous retroviruses in autoimmune diseases. A Perl, Rheum Dis Clin North Am 2003 29 123 143 vii 10.1016/S0889-857X(02)00098-4 12635504 (Pubitemid 36298107)
9. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. JM Yarwood DY Leung PM Schlievert, FEMS Microbiol Lett 2000 192 1 7 10.1111/j.1574-6968.2000.tb09350.x 11040420
10. Inflammatory papillomatous hyperplasia and epidermal necrosis in a transgenic rat for HIV-1. F Cedeno-Laurent J Bryant R Fishelevich OD Jones A Deng ML Eng AA Gaspari JR Trujillo, J Dermatol Sci 2009 53 112 119 10.1016/j.jdermsci.2008.08.015 19004620
11. Transgenic models of HIV-1. PE Klotman J Rappaport P Ray JB Kopp R Franks LA Bruggeman AL Notkins, AIDS 1995 9 313 324 7794536
12. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. P Dickie F Ramsdell AL Notkins S Venkatesan, Virology 1993 197 431 438 10.1006/viro.1993.1607 8212579
13. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. A Corallini G Altavilla L Pozzi F Bignozzi M Negrini P Rimessi F Gualandi G Barbanti-Brodano, Cancer Res 1993 53 5569 5575 8221699 (Pubitemid 23342186)
14. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. J Vogel SH Hinrichs RK Reynolds PA Luciw G Jay, Nature 1988 335 606 611 10.1038/335606a0 2845275
15. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. E Langhoff EF Terwilliger HJ Bos KH Kalland MC Poznansky OM Bacon WA Haseltine, Proc Natl Acad Sci USA 1991 88 7998 8002 10.1073/pnas.88.18.7998 1910172 (Pubitemid 21915282)
16. Primary HIV infection: host responses and intervention strategies. B Tindall DA Cooper, AIDS 1991 5 1 14 10.1097/00002030-199101000-00001 1812848
17. Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. DV Belsito MR Sanchez RL Baer F Valentine GJ Thorbecke, N Engl J Med 1984 310 1279 1282 10.1056/ NEJM198405173102002 6232458 (Pubitemid 14138759)
18. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. E Tschachler V Groh M Popovic DL Mann K Konrad B Safai L Eron F diMarzo Veronese K Wolff G Stingl, J Invest Dermatol 1987 88 233 237 10.1111/1523-1747.ep12525402 3100656 (Pubitemid 17009009)
19. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. J Ward Z Davis J DeHart E Zimmerman A Bosque E Brunetta D Mavilio V Planelles E Barker, PLoS Pathog 2009 5 1000613 10.1371/journal.ppat.1000613 19798433
20. Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. P Mantegani G Tambussi L Galli CT Din A Lazzarin C Fortis, Immunology 129 220 233 10.1111/j.1365-2567.2009.03171.x 19824914
21. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. M Pope MG Betjes N Romani H Hirmand PU Cameron L Hoffman S Gezelter G Schuler RM Steinman, Cell 1994 78 389 398 10.1016/0092-8674(94)90418-9 7914836 (Pubitemid 24250804)
22. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group. FM Gordin PM Hartigan NG Klimas SB Zolla-Pazner MS Simberkoff JD Hamilton, J Infect Dis 1994 169 893 897 7907646 (Pubitemid 24102129)
23. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. SK Hira D Wadhawan J Kamanga D Kavindele R Macuacua PS Patil MA Ansary AM Macher PL Perine, J Am Acad Dermatol 1988 19 451 457 10.1016/S0190-9622(88) 70197-8 2971691
24. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. M Josephine E Issac A George M Ngole SE Albert, Int J Dermatol 2006 45 280 284 10.1111/j.1365-4632.2004.02529.x 16533229
25. Spectrum of opportunistic infections among AIDS patients in Tamil Nadu, India. N Kumarasamy S Solomon SA Jayaker Paul R Venilla RE Amalraj, Int J STD AIDS 1995 6 447 449 8845406 (Pubitemid 26005666)
26. Etiology of pruritic papular eruption with HIV infection in Uganda. JS Resneck Jr M Van Beek L Furmanski J Oyugi PE LeBoit E Katabira F Kambugu T Maurer T Berger MJ Pletcher EL Machtinger, JAMA 2004 292 2614 2621 10.1001/jama.292.21.2614 15572719 (Pubitemid 39577517)
27. Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. R Spira M Mignard MS Doutre P Morlat F Dabis, Arch Dermatol 1998 134 1208 1212 10.1001/archderm.134.10.1208 9801675 (Pubitemid 28513255)
28. Mucocutaneous manifestations of HIV infection: a retrospective analysis of 145 cases in a Chinese population in Malaysia. W Jing R Ismail, Int J Dermatol 1999 38 457 463 10.1046/j.1365-4362.1999.00644.x 10397587 (Pubitemid 29287642)
29. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. T Maurer LK Rodrigues N Ameli N Phanuphak SJ Gange J DeHovitz AL French M Glesby C Jordan A Khalsa NA Hessol, Clin Infect Dis 2004 38 579 584 10.1086/381264 14765353 (Pubitemid 38250970)
30. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. BM Mathes MC Douglass, J Am Acad Dermatol 1985 13 947 951 10.1016/S0190-9622(85)70243-5 2934444 (Pubitemid 16070103)
31. Seborrheic dermatitis and atopic eczema in human immunodeficiency virus infection. M Froschl HG Land M Landthaler, Semin Dermatol 1990 9 230 232 2145024 (Pubitemid 20319934)
32. Etiopathogenesis of seborrheic dermatitis. RG Valia, Indian J Dermatol Venereol Leprol 2006 72 253 255 10.4103/0378-6323.26711 16880569
33. Bacterial, viral, fungal, and parasitic infections in HIV disease and AIDS. TG Berger I Greene, Dermatol Clin 1991 9 465 492 10.1016/0738-081X(91) 90120-A 1873926
34. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. JR Wikler C Nieboer R Willemze, J Am Acad Dermatol 1992 27 37 39 10.1016/0190-9622(92)70153-7 1535637
35. Cell-mediated immunity to Malassezia furfur in patients with seborrhoeic dermatitis and pityriasis versicolor. IM Bergbrant B Andersson J Faergemann, Clin Exp Dermatol 1999 24 402 406 10.1046/j.1365-2230.1999.00512.x 10564332 (Pubitemid 29491215)
36. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. J Faergemann IM Bergbrant M Dohse A Scott G Westgate, Br J Dermatol 2001 144 549 556 10.1046/j.1365-2133.2001.04082.x 11260013 (Pubitemid 32232010)
37. Histopathologic differentiation of eczematous dermatitides from psoriasis and seborrheic dermatitis. AB Ackerman, Cutis 1977 20 619 623 144590 (Pubitemid 8221515)
38. Seborrheic dermatitis and butterfly rash in AIDS. BA Eisenstat GP Wormser, N Engl J Med 1984 311 189 6234466 (Pubitemid 14092912)
39. Epidermal expression of 65 and 72 kd heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis. L Puig MT Fernandez-Figueras C Ferrandiz M Ribera JM de Moragas, J Am Acad Dermatol 1995 33 985 989 10.1016/0190-9622(95)90291-0 7490370
40. Is seborrhoeic dermatitis a clinical marker of HIV disease? F Ippolito S Passi A Di Carlo, Minerva Ginecol 2000 52 54 58 11526689 (Pubitemid 33621653)
41. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. BM Coldiron PR Bergstresser, Arch Dermatol 1989 125 357 361 10.1001/archderm.125.3.357 2522293 (Pubitemid 19078242)
42. HIV-associated pruritus: etiology and management. F Singh D Rudikoff, Am J Clin Dermatol 2003 4 177 188 10.2165/00128071-200304030-00004 12627993 (Pubitemid 36390474)
43. Asthma and related atopic disorders in outpatients attending an urban HIV clinic. RY Lin TS Lazarus, Ann Allergy Asthma Immunol 1995 74 510 515 7788519
44. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. M Yoshioka WG Bradley P Shapshak I Nagano RV Stewart KQ Xin AK Srivastava S Nakamura, Adv Neuroimmunol 1995 5 335 358 10.1016/0960-5428(95) 00012-Q 8748077
45. Depletion of cutaneous peptidergic innervation in HIV-associated xerosis. A Rowe E Mallon P Rosenberger M Barrett J Walsh CB Bunker, J Invest Dermatol 1999 112 284 289 10.1046/j.1523-1747.1999.00508.x 10084303 (Pubitemid 29125102)
46. Evaluation and treatment of itching in HIV-infected patients. JM Gelfand D Rudikoff, Mt Sinai J Med 2001 68 298 308 11514917 (Pubitemid 32717825)
47. Acquired immunodeficiency syndrome in infants. GB Scott BE Buck JG Leterman FL Bloom WP Parks, N Engl J Med 1984 310 76 81 10.1056/ NEJM198401123100202 6606781 (Pubitemid 14214863)
48. Immune dysregulation in atopic dermatitis. PY Ong DY Leung, Curr Allergy Asthma Rep 2006 6 384 389 10.1007/s11882-996-0008-5 16899200 (Pubitemid 44340170)
49. HIV-related eosinophilic folliculitis: a panel discussion. MJ Majors TG Berger A Blauvelt KJ Smith ML Turner PD Cruz Jr, Semin Cutan Med Surg 1997 16 219 223 10.1016/S1085-5629(97)80045-4 9300633 (Pubitemid 27371939)
50. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. P Anand DR Springall MA Blank D Sellu JM Polak SR Bloom, Br J Dermatol 1991 124 547 549 10.1111/j.1365-2133.1991.tb04948.x 1712221
51. Superantigens and their association with dermatological inflammatory diseases: facts and hypotheses. U Jappe, Acta Derm Venereol 2000 80 321 328 10.1080/000155500459231 11200827 (Pubitemid 32014446)
52. Atopic dermatitis and the immune system: the role of superantigens and bacteria. DY Leung, J Am Acad Dermatol 2001 45 13 16 10.1067/mjd.2001.117024 11423865
53. Chronic diffuse dermatitis and hyper-IgE in HIV infection. RY Lin, Acta Derm Venereol 1988 68 486 491 2467486 (Pubitemid 18265621)
54. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. M Duvic TM Johnson RP Rapini T Freese G Brewton A Rios, Arch Dermatol 1987 123 1622 1632 10.1001/archderm.123.12.1622 3688903 (Pubitemid 18012175)
55. Psoriasis. MP Schon WH Boehncke, N Engl J Med 2005 352 1899 1912 10.1056/NEJMra041320 15872205 (Pubitemid 40627816)
56. Paradoxical exacerbation of psoriasis in AIDS: proposed explanations including the potential roles of substance P and gram-negative bacteria. MR Namazi, Autoimmunity 2004 37 67 71 10.1080/08916930310001637986 15115314 (Pubitemid 38185912)
57. AIDS exacerbates psoriasis. TM Johnson M Duvic RP Rapini A Rios, N Engl J Med 1985 313 1415 4058535 (Pubitemid 16211844)
58. Cutaneous manifestations of human immunodeficiency virus infection. Part II. JS Dover RA Johnson, Arch Dermatol 1991 127 1549 1558 10.1001/archderm.127. 10.1549 1929464
59. Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. FC Arnett JD Reveille M Duvic, Rheum Dis Clin North Am 1991 17 59 78 2041889
60. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. U Bartke I Venten A Kreuter S Gubbay P Altmeyer NH Brockmeyer, Br J Dermatol 2004 150 784 786 10.1111/j.0007-0963.2004.05885.x 15099388 (Pubitemid 38586243)
61. Immunology of AIDS related to psoriasis. M Duvic, J Invest Dermatol 1990 95 38S 40S 10.1111/1523-1747.ep12505743
62. HIV-associated psoriasis. E Mallon CB Bunker, AIDS Patient Care STDS 2000 14 239 246 10.1089/108729100317696 10833810 (Pubitemid 30321653)
63. Psoriasis and human immunodeficiency virus infection. ML Obuch TA Maurer B Becker TG Berger, J Am Acad Dermatol 1992 27 667 673 10.1016/0190-9622(92) 70234-7 1430384
64. HLA-Cw*0602 and HIV-associated psoriasis. E Mallon D Young M Bunce FM Gotch PJ Easterbrook R Newson CB Bunker, Br J Dermatol 1998 139 527 533 10.1046/j.1365-2133.1998.02495.x 9767306
65. Erythroderma: a comparison between HIV positive and negative patients. N Morar N Dlova AK Gupta DK Naidoo J Aboobaker PK Ramdial, Int J Dermatol 1999 38 895 900 10.1046/j.1365-4362.1999.00846.x 10632767 (Pubitemid 30002737)
66. Retroviruses and psoriasis. E Mallon, Curr Opin Infect Dis 2000 13 103 107 11964775 (Pubitemid 30223742)
67. Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study. BL Townsend PR Cohen M Duvic, J Am Acad Dermatol 1995 32 994 999 10.1016/0190-9622(95)91338-6 7751471
68. Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy. T Fischer H Schworer C Vente K Reich G Ramadori, AIDS 1999 13 628 629 10.1097/00002030- 199904010-00018 10203394 (Pubitemid 29286735)
69. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. JP Moles A Tesniere JJ Guilhou, Br J Dermatol 2005 153 83 89 10.1111/j.1365-2133.2005.06555.x 16029331 (Pubitemid 41044532)
70. Human endogenous retroviruses and their possible impact on dermatology. A Rebora, J Am Acad Dermatol 2005 52 7 10.1016/S0190-9622(03)02540-4 15858463
71. Genetics. L1 retrotransposons shape the mammalian genome. HH Kazazian Jr, Science 2000 289 1152 1153 10.1126/science.289.5482.1152 10970230
72. Endogenous retroviruses: potential etiologic agents in autoimmunity. AM Krieg MF Gourley A Perl, Faseb J 1992 6 2537 2544 1592206
73. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. DJ Griffiths SP Cooke C Herve SP Rigby E Mallon A Hajeer M Lock V Emery P Taylor P Pantelidis CB Bunker R du Bois RA Weiss PJ Venables, Arthritis Rheum 1999 42 448 454 10.1002/1529-0131(199904)42:3<448::AID- ANR9>3.0.CO;2-8 10088767 (Pubitemid 29136092)
74. Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AM Krieg MF Gourley DM Klinman A Perl AD Steinberg, AIDS Res Hum Retroviruses 1992 8 1991 1998 10.1089/aid.1992.8.1991 1493049 (Pubitemid 23054099)
75. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. C Hohenadl H Germaier M Walchner M Hagenhofer M Herrmann M Sturzl P Kind R Hehlmann V Erfle C Leib-Mosch, J Invest Dermatol 1999 113 587 594 10.1046/j.1523-1747.1999.00728.x 10504445 (Pubitemid 29489621)
76. Expression and biological significance of human endogenous retroviral sequences. C Leib-Mosch M Bachmann R Brack-Werner T Werner V Erfle R Hehlmann, Leukemia 1992 6 Suppl 3 72S 75S 1602831
77. A virus-like particle associated with psoriasis. AB Dalen L Hellgren OJ Iversen J Vincent, Acta Pathol Microbiol Immunol Scand [B] 1983 91 221 229 6624461 (Pubitemid 13039874)
78. Characterization of virus-like particles from a psoriatic patient with respect to the possible presence of particle-associated RNA and RNA-directed DNA polymerase. OJ Iversen J Nissen-Meyer AB Dalen, Acta Pathol Microbiol Immunol Scand [B] 1983 91 413 417 6201035 (Pubitemid 14182699)
79. The major internal protein, p27, of a retrovirus-like particle is expressed in blood lymphocytes from psoriatic patients. OJ Iversen AB Dalen, Arch Virol 1985 85 197 207 10.1007/BF01314231 4026580 (Pubitemid 15247842)
80. High prevalence of an IgG response against murine leukemia virus (MLV) in patients with psoriasis. JP Moles JC Hadi JJ Guilhou, Virus Res 2003 94 97 101 10.1016/S0168-1702(03)00137-0 12902038
81. Molecular mimicry and autoimmune disease. MB Oldstone, Cell 1987 50 819 820 10.1016/0092-8674(87)90507-1 3621346
82. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. FF Soeprono RA Schinella, J Am Acad Dermatol 1986 14 1020 1022 10.1016/S0190-9622(86)70126-6 3722478 (Pubitemid 16090438)
83. Eosinophilic pustular folliculitis. AS Colton L Schachner AP Kowalczyk, J Am Acad Dermatol 1986 14 469 474 10.1016/S0190-9622(86)70059-5 3958258 (Pubitemid 16167260)
84. Eosinophilic folliculitis. The histologic spectrum. TH McCalmont D Altemus T Maurer TG Berger, Am J Dermatopathol 1995 17 439 446 10.1097/00000372-199510000-00002 8599447
85. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. PM Rajendran JC Dolev MR Heaphy Jr T Maurer, Arch Dermatol 2005 141 1227 1231 10.1001/archderm.141.10.1227 16230559 (Pubitemid 41498919)
86. Eosinophilic pustular folliculitis: a sterile folliculitis of unknown cause? S Brenner R Wolf J Ophir, J Am Acad Dermatol 1994 31 210 212 10.1016/S0190-9622(94)70148-2 8040403 (Pubitemid 24242854)
87. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. LA Fearfield A Rowe N Francis CB Bunker RC Staughton, Br J Dermatol 1999 141 3 11 10.1046/j.1365-2133.1999.02914.x 10417509 (Pubitemid 29333687)
88. Necrotizing eosinophilic folliculitis as a manifestation of the atopic diathesis. CM Magro AN Crowson, Int J Dermatol 2000 39 672 677 10.1046/j.1365-4362.2000.00973.x 11044192
89. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. D Rosenthal PE LeBoit L Klumpp TG Berger, Arch Dermatol 1991 127 206 209 10.1001/archderm.127.2.206 1671328
90. Immune restoration disease after antiretroviral therapy. MA French P Price SF Stone, AIDS 2004 18 1615 1627 10.1097/01.aids.0000131375.21070.06 15280772 (Pubitemid 39095778)
91. Increased cutaneous toxicity to ionizing radiation in HIV-positive patients. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). KJ Smith HG Skelton S Tuur J Yeager C Decker KF Wagner, Int J Dermatol 1997 36 779 782 10.1046/j.1365-4362.1997.00255.x 9372357
92. Vitiligo in association with human immunodeficiency virus infection. FC Antony RA Marsden, J Eur Acad Dermatol Venereol 2003 17 456 458 10.1046/j.1468-3083.2003.00762.x 12834461 (Pubitemid 36869314)
93. Porphyria cutanea tarda associated with human immunodeficiency virus infection. C Drobacheff C Derancourt H Van Landuyt D Devred B de Wazieres B Cribier D Rey JM Lang C Grosieux B Kalis R Laurent, Eur J Dermatol 1998 8 492 496 9854161 (Pubitemid 28474144)
94. Granuloma annulare and human immunodeficiency virus infection. JR Toro P Chu TS Yen PE LeBoit, Arch Dermatol 1999 135 1341 1346 10.1001/archderm.135.11. 1341 10566832
95. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS. RA Bonomo N Korman L Nagashima-Whalen J Briggs R Graham RA Salata, Am J Med Sci 1997 314 118 121 10.1097/00000441-199708000-00014 9258214 (Pubitemid 27335240)
96. Autoimmune blistering diseases associated with HIV infection. RH Bull ME Fallowfield RA Marsden, Clin Exp Dermatol 1994 19 47 50 10.1111/j.1365-2230. 1994.tb01114.x 8313636 (Pubitemid 24216561)
97. Porphyria cutanea tarda in a patient with HIV-infection. A Almehmi H Deliri GG Szego AC Teague AK Pfister SA Martin, W V Med J 2005 101 19 21 15861867
98. Porphyria cutanea tarda and HIV: two cases associated with hepatitis C. WJ O'Connor, AIDS Patient Care STDS 1998 12 341 346 11361969 (Pubitemid 28243703)
99. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective. G Todd, Dermatol Clin 2006 24 459 472 vi 10.1016/j.det.2006.06.008 17010776 (Pubitemid 44436795)
100. Role of xanthine oxidase in the interferon-mediated depression of the hepatic cytochrome P-450 system in mice. GJ Mannering LB Deloria V Abbott, Cancer Res 1988 48 2107 2112 2450644
101. The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus. DF Lehmann A Liu N Newman DC Blair, J Clin Pharmacol 1999 39 533 537 10234602 (Pubitemid 29356475)
102. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. A Rotunda RJ Hirsch N Scheinfeld JM Weinberg, Acta Derm Venereol 2003 83 1 9 10.1080/00015550310002611 12636014 (Pubitemid 36223045)
103. Erythema multiforme as a presentation of human immunodeficiency virus seroconversion illness. DA Lewis MG Brook, Int J STD AIDS 1992 3 56 57 1543771
104. Primary infection with human immunodeficiency virus that presented as Stevens-Johnson syndrome. E Mortier JR Zahar I Gros JP Vignali AM Simonpoli J Pouchot P Vinceneux, Clin Infect Dis 1994 19 798 7803658 (Pubitemid 24301169)
105. Acute human immunodeficiency virus infection presenting with erythema multiforme. AJ Schechner AG Pinson, Am J Emerg Med 2004 22 330 331 10.1016/j.ajem.2004.04.026 15258890 (Pubitemid 38918263)
106. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. S Sawada K Gowrishankar R Kitamura M Suzuki G Suzuki S Tahara A Koito, J Exp Med 1998 187 1439 1449 10.1084/jem.187.9.1439 9565636 (Pubitemid 28215403)
107. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. OT Keppler FJ Welte TA Ngo PS Chin KS Patton CL Tsou NW Abbey ME Sharkey RM Grant Y You JD Scarborough W Ellmeier DR Littman M Stevenson IF Charo BG Herndier RF Speck MA Goldsmith, J Exp Med 2002 195 719 736 10.1084/jem.20011549 11901198 (Pubitemid 34259717)
108. Rodent models for HIV-1 infection and disease. M van Maanen RE Sutton, Curr HIV Res 2003 1 121 130 10.2174/1570162033352075 15043216
109. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. W Reid M Sadowska F Denaro S Rao J Foulke Jr N Hayes O Jones D Doodnauth H Davis A Sill P O'Driscoll D Huso T Fouts G Lewis M Hill R Kamin-Lewis C Wei P Ray RC Gallo M Reitz J Bryant, Proc Natl Acad Sci USA 2001 98 9271 9276 10.1073/pnas.161290298 11481487 (Pubitemid 32743906)
110. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. JB Kopp JF Rooney C Wohlenberg N Dorfman NJ Marinos JL Bryant SI Katz AL Notkins PE Klotman, AIDS Res Hum Retroviruses 1993 9 267 275 10.1089/aid.1993.9.267 8471318 (Pubitemid 23108522)
111. Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. C Vellutini N Horschowski V Philippon D Gambarelli KA Nave P Filippi, AIDS Res Hum Retroviruses 1995 11 21 29 10.1089/aid.1995.11.21 7537511
112. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. P Wei ME Garber SM Fang WH Fischer KA Jones, Cell 1998 92 451 462 10.1016/S0092-8674(00) 80939-3 9491887 (Pubitemid 28101109)
113. HIV-1 transgenic rats develop T cell abnormalities. W Reid S Abdelwahab M Sadowska D Huso A Neal A Ahearn J Bryant RC Gallo GK Lewis M Reitz, Virology 2004 321 111 119 10.1016/j.virol.2003.12.010 15033570 (Pubitemid 38368108)
114. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. Z Sun PW Denton JD Estes FA Othieno BL Wei AK Wege MW Melkus A Padgett-Thomas M Zupancic AT Haase JV Garcia, J Exp Med 2007 204 705 714 10.1084/jem.20062411 17389241 (Pubitemid 46631601)
115. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin. N Delhem F Hadida G Gorochov F Carpentier JP de Cavel JF Andreani B Autran JY Cesbron, J Immunol 1998 161 2060 2069 9712080 (Pubitemid 28387633)
116. Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals. CA Stoddart CA Bales JC Bare G Chkhenkeli SA Galkina AN Kinkade ME Moreno JM Rivera RE Ronquillo B Sloan PL Black, PLoS One 2007 2 655 10.1371/journal.pone.0000655 17668043
117. The Tetratricopeptide repeat domain 7 gene is mutated in flaky skin mice: a model for psoriasis, autoimmunity, and anemia. C Helms S Pelsue L Cao E Lamb B Loffredo P Taillon-Miller B Herrin LM Burzenski B Gott BL Lyons D Keppler LD Shultz AM Bowcock, Exp Biol Med (Maywood) 2005 230 659 667 16179734 (Pubitemid 41506861)